- Home
- VYX vs MDXG Comparison
VYX vs MDXG Comparison
Compare VYX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYX
- MDXG
- Stock Information
- Founded
- VYX 1881
- MDXG 2006
- Country
- VYX United States
- MDXG United States
- Employees
- VYX N/A
- MDXG N/A
- Industry
- VYX
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- VYX
- MDXG Health Care
- Exchange
- VYX Nasdaq
- MDXG Nasdaq
- Market Cap
- VYX 1.5B
- MDXG 1.0B
- IPO Year
- VYX N/A
- MDXG N/A
- Fundamental
- Price
- VYX $11.07
- MDXG $6.43
- Analyst Decision
- VYX Strong Buy
- MDXG Strong Buy
- Analyst Count
- VYX 5
- MDXG 2
- Target Price
- VYX $14.60
- MDXG $12.50
- AVG Volume (30 Days)
- VYX 1.9M
- MDXG 852.6K
- Earning Date
- VYX 05-08-2025
- MDXG 04-30-2025
- Dividend Yield
- VYX N/A
- MDXG N/A
- EPS Growth
- VYX N/A
- MDXG N/A
- EPS
- VYX 6.72
- MDXG 0.27
- Revenue
- VYX $2,733,000,000.00
- MDXG $352,375,000.00
- Revenue This Year
- VYX N/A
- MDXG $9.44
- Revenue Next Year
- VYX N/A
- MDXG $11.54
- P/E Ratio
- VYX $1.58
- MDXG $23.82
- Revenue Growth
- VYX N/A
- MDXG 5.34
- 52 Week Low
- VYX $7.55
- MDXG $5.47
- 52 Week High
- VYX $15.34
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- VYX 64.15
- MDXG 38.95
- Support Level
- VYX $10.38
- MDXG $6.46
- Resistance Level
- VYX $11.36
- MDXG $6.90
- Average True Range (ATR)
- VYX 0.31
- MDXG 0.23
- MACD
- VYX 0.04
- MDXG -0.05
- Stochastic Oscillator
- VYX 70.41
- MDXG 1.02
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.